Haemonetics Corporation Proceeds from Long-term Lines of Credit
Haemonetics Corporation (HAE) reported Proceeds from Long-term Lines of Credit of $300.00 million for the 12-month period ending 2026-03-28, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-05-20
- Haemonetics Corporation proceeds from long-term lines of credit for the quarter ending 2025-03-29 was $0.00.
- Haemonetics Corporation proceeds from long-term lines of credit for the quarter ending 2024-03-30 was $0.00.
- Haemonetics Corporation proceeds from long-term lines of credit for the quarter ending 2023-12-30 was $110.00M.
- Haemonetics Corporation proceeds from long-term lines of credit for the quarter ending 2023-04-01 was $0.00.
- Haemonetics Corporation proceeds from long-term lines of credit for fiscal 2026 was $300.00M.
- Haemonetics Corporation proceeds from long-term lines of credit for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Haemonetics Corporation proceeds from long-term lines of credit for fiscal 2024 was $110.00M, a 120.00% increase from fiscal 2023.
- Haemonetics Corporation proceeds from long-term lines of credit for fiscal 2023 was $50.00M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-03-28 | $300.00M 10-K · filed 2026-05-20 | |||
| 2025-03-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $0.00 10-K · filed 2026-05-20 | ||
| 2024-12-28 | $0.00 10-Q · filed 2025-02-06 | |||
| 2024-03-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $110.00M derived: sum of 2 quarters · filed 2026-05-20 | $110.00M 10-K · filed 2026-05-20 | |
| 2023-12-30 | $110.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $110.00M 10-Q · filed 2025-02-06 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | |||
| 2023-04-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21 | $0.00 derived: sum of 2 quarters · filed 2025-05-21 | $50.00M 10-K · filed 2025-05-21 | |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $50.00M 10-Q · filed 2024-02-08 | ||
| 2022-10-01 | $50.00M 10-Q · filed 2023-11-02 | |||
| 2022-04-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-20 | $0.00 derived: sum of 2 quarters · filed 2024-05-20 | $0.00 10-K · filed 2024-05-20 | |
| 2022-01-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-07 | $0.00 10-Q · filed 2023-02-07 | ||
| 2021-10-02 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-04-03 | $0.00 10-K · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |